- ATMI (ATMI) has agreed to sell its LifeSciences unit to Pall Corp. (PLL) in a deal worth $185M, with after-tax proceeds to be $165M.
- The sale is part of ATMI's "ongoing exploration of strategic alternatives," the company said.
- The assets of the LifeSciences business include two Belgian sites and a shared facility in Minnesota. (PR)
From other sites
at CNBC.com (Mar 25, 2014)
at Fox Business (Feb 4, 2014)
at CNBC.com (Nov 1, 2013)
at MarketWatch.com (Apr 25, 2012)
at CNBC.com (Jan 26, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs